Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "Base Editing Market by Products & Services, by Type, by Application, by End-User, and By Region" report has been added to ResearchAndMarkets.com's...
-
The world’s first zero-off-target base-edited NK cell product has received IND approvals from both the U.S. FDA and China’s NMPA.
-
Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The "Global Base Editing Market by Product (Platform, Reagents & Kits, Plasmids), Service (gRNA Design, Cell Line Engineering), Type, Targeted Base...
-
Early candidate from XVIR-TAT series demonstrated genetic elimination of HIV and robust anti-retroviral activity with CRISPR-Cas9 based excision Exavir lipid nanoparticles (LNPs) with mRNA...
-
CAMBRIDGE, Mass., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today has been named...
-
CAMBRIDGE, Mass., March 16, 2020 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced key...